Trials / Unknown
UnknownNCT05402852
Effectiveness and Safety of EuBone® Capsules for Bone Health in Postmenopausal Women
Effectiveness and Safety of EuBone® Capsules for Bone Health in Postmenopausal Women：A Randomized, Double-blind, Placebo-controlled Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Shandong University · Academic / Other
- Sex
- Female
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
EuBone is prepared by mixing eucommia ulmoides extract, fructus ulmoides extract and dodder extract in proportion. The aim of this study is to evaluate the effectiveness and safety of EuBone® capsules in slowing bone loss, preventing bone loss, and improving quality of life compared with placebo in Postmenopausal women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EuBone ® capsule | Subjects are given EuBone® capsules, 4 capsules ×500mg/capsule per day for 360 days. |
| DRUG | placebo | Subjects are given placebo capsules, 4 capsules ×500mg/capsule per day for 360 days. |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2022-10-31
- Completion
- 2023-12-31
- First posted
- 2022-06-02
- Last updated
- 2022-06-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05402852. Inclusion in this directory is not an endorsement.